Cargando…
Analysis of the expression and potential molecular mechanism of interleukin-1 receptor antagonist (IL1RN) in papillary thyroid cancer via bioinformatics methods
BACKGROUND: Interleukin-1 receptor antagonist (IL1RN) has been reported as a biomarker of many cancers. However, the biological function of IL1RN in papillary thyroid carcinoma (PTC) remains undetermined. METHODS: We obtained IL1RN expression data from The Cancer Genome Atlas (TCGA) database. Enrich...
Autores principales: | Xie, Zhenyu, Li, Xin, He, Yuzhen, Wu, Song, Wang, Shiyue, Sun, Jianjian, He, Yuchen, Lun, Yu, Xin, Shijie, Zhang, Jian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7687764/ https://www.ncbi.nlm.nih.gov/pubmed/33238942 http://dx.doi.org/10.1186/s12885-020-07620-8 |
Ejemplares similares
-
Analysis of the Prognostic Value and Potential Molecular Mechanisms of TREM-1 Overexpression in Papillary Thyroid Cancer via Bioinformatics Methods
por: Xie, Zhenyu, et al.
Publicado: (2021) -
Bioinformatics analysis of the clinical value and potential mechanisms of AHNAK2 in papillary thyroid carcinoma
por: Xie, Zhenyu, et al.
Publicado: (2020) -
Immune Cell Confrontation in the Papillary Thyroid Carcinoma Microenvironment
por: Xie, Zhenyu, et al.
Publicado: (2020) -
Association between the Interleukin-1 Receptor Antagonist (IL1RN) Variable Number of Tandem Repeats (VNTR) Polymorphism and Lymphoma
por: Sarani, Hosna, et al.
Publicado: (2021) -
Deficiency of Interleukin-1 Receptor Antagonist (DIRA): Report of the First Indian Patient and a Novel Deletion Affecting IL1RN
por: Mendonca, LO, et al.
Publicado: (2015)